Opportunities and Resources
In The News
New Funding Opportunities
For the past few years, you could resubmit just one time if your initial application didn't succeed.
Now you can send a new (A0) application without NIH's requiring you to make substantial changes to the scientific direction or scope. This means after an unsuccessful application, you can send a new application in the same scientific vein.
A new (A0) application always gets a new serial number, and there is no formal link between it and any prior application.
For the official announcement, including reasons for the change, see the April 17, 2014, Guide notice. Also see the updated FAQ on Resubmissions of NIH Applications.
You can take advantage of this for your next due date since the policy kicked in for due dates after April 16. The first standard due date affected is May 7, 2014, for AIDS and AIDS-related applications.
You must wait for your summary statement from the previous application's review before sending a new application or else NIH might consider it an overlapping application with the previous one. An application is considered under review until the summary statement is released (that rule is still in effect). Also, you can't send an overlapping application while a prior similar one is under appeal. Learn more at Evaluation of Overlapping Applications.
Now that you aren’t obligated to make substantial changes in scientific direction or scope after an unsuccessful application, you'll have to decide whether that's the right move. See our advice below and discuss with your program officer.
We're still working on site updates to reflect this breaking news. Meanwhile, our advice probably sounds familiar: always strive to enhance your next application.
For all applications:
For an A0 application in the same vein as a prior application, also do the following:
One last note: if you plan to send multiple applications on non-overlapping topics, consider staggering your timing so they don't both end up in the same study section for the same round of initial peer review. Otherwise, you're competing with yourself.
As we update our site, we'll list the changes on Latest Funding Updates. We'll also share any new advice for you in follow-up articles.
If you have any questions or feedback about how this new policy affects you, email us at email@example.com.
Since 2004, NIAID has supported the Atopic Dermatitis Research Network (ADRN), which conducts clinical research studies to better understand host defense mechanisms in the skin.
We encourage applicants to respond to a funding opportunity announcement (FOA) that supports the continuation of the ADRN.
Areas of Research Interest
The FOA has several research areas of interest, such as:
The majority of research that ADRN conducts should involve human subjects, but animal studies may be included if they 1) provide information that can't be obtained by human studies and 2) are directly linked to ongoing or planned human studies.
Projects to Be Included
A multiproject application is required and must include both clinical and mechanistic study projects.
Clinical projects fall into the following categories. In addition to the required four clinical projects (two for each category), applicants may propose up to two others (either interventional clinical trials or clinical studies).
Mechanistic studies, which should involve human subjects, must be part of both interventional clinical trials and clinical studies projects and be aimed at:
For complete details, including further information on research studies and objectives, read the March 20, 2014, Guide notice.
Deadlines, Writing Help
Optional letters of intent are due June 8, 2014, with applications due a month later on July 8.
For help in writing a multiproject application, as well as information on electronic submission, go to Guidance for Preparing a Multiproject Research Application.
NIAID has issued a funding opportunity announcement (FOA) for multiproject cooperative agreements (U19) to develop computational models of immunity to infectious diseases. Using computational modeling and immunological experimentation, applicants will develop, refine, and validate models of immune responses either during or following infection or before and after vaccination.
Applicants will propose two to four research projects arranged around a central scientific theme.
Areas of interest include the dynamics of innate immune responses, mechanisms of adaptive immune pathways, and homeostatic mechanisms that maintain protective immunity.
Be sure to follow the eligibility requirements listed in the FOA, including:
In addition, the following are not permitted:
Applications must include an Administrative core and an Infrastructure and Opportunities Fund (IOF) Management core. They may also propose Optional Service cores. For advice on writing an effective multiproject application, see Guidance for Preparing a Multiproject Research Application.
NIAID intends to fund three or four awardees. Following review, NIAID will choose one institution from among the successful applicants to manage the IOF for the entire network. All awardees are expected to share their computational models and data through a publicly accessible repository(ies).
Optional letters of intent are due June 18, 2014. Applications are due July 18, 2014.
Attention small businesses: Check out two funding opportunity announcements (FOAs) to develop new approaches, standards, methods, tools, software, and competencies to improve scientific use of "big data."
For each opportunity, you'll have a chance to focus on technologies for biomedical computing and informatics across all of NIH's research areas.
If that seems exceptionally broad to you, we concur—and that's the point.
These opportunities are looking for dynamic, innovative projects that have the potential to generate major changes in how scientists conduct research, from basic biomedicine to research targeted to organ systems and diseases.
NIH's Division of Receipt and Referral will send us applications that fit within our mission area, but as always, you may request assignment to NIAID in your cover letter.
Read the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) FOAs for details, including topic areas, application instructions, and NIAID contacts.
These funding opportunities come from NIH's Big Data to Knowledge (BD2K) program, an effort to improve biomedical use of data sets and databases that are too large or complex for conventional research approaches.
Learn more about it at Big Data to Knowledge (BD2K). Also see other BD2K Funding Opportunities and Notices.
Antiretroviral therapy cannot fully eliminate latently-infected CD4+ T cells, which is a major obstacle to achieving an HIV cure. NIAID now seeks an approach that can selectively eliminate HIV-1 latently-infected cells without depending on viral reactivation or viral protein expression.
Toward that end, we are looking to fund R01 research projects that:
Innovative thinking and cutting-edge technology are imperative. To ensure your application is eligible, read the March 25, 2014, Guide notice for specific examples of nonresponsive areas of research, such as clinical trials or studies that rely solely on intensification of antiretroviral therapy.
Send optional letters of intent by June 15, 2014. Apply by July 15, 2014.
eRA Database Downtime Scheduled for Late May. The electronic Research Administration (eRA) system will be offline for scheduled maintenance from 9:00 a.m. on May 23 until 7:00 a.m. on May 27, 2014. As a result, due dates that fall on or between May 25 and May 28, 2014, will move to May 29, 2014. If you are preparing a multiproject application using ASSIST, you will not have access to your application during the downtime and should plan accordingly.
SBIR/STTR Webinar Resources Available Online. Materials from the NIH SBIR/STTR Presubmission Updates Webinar are now posted, including video, slides, and transcript.
Two Requests for Information About Chimp Facilities. In an April 4, 2014, Guide notice, NIH recommended that the primary living space of chimpanzees be at least 250 square feet per animal. NIH now seeks feedback from researchers with experience maintaining chimpanzees, as requested in two RFIs—NOT-OD-14-067 and NOT-OD-14-075—with responses due April 30, 2014, and June 2, 2014, respectively.
You Can Nominate an SBIR/STTR Champion. Nominations for the prestigious 2014 Tibbetts and SBIR Hall of Fame Awards are open until May 2, 2014. In June 2014, winners will attend a White House Awards Program in Washington, D.C. and be honored at the annual SBIR National Conference in National Harbor, Maryland.
Upcoming International Grants Management Workshop. An NIAID Grants Policy and Management Training Workshop will take place in Dar es Salaam, Tanzania, from June 23 to 25, 2014. Check out the Agenda and Register now.
Save the Date for Future Small Business Conferences. This year's NIAID SBIR/STTR Workshop will take place in Cambridge, Massachusetts, on September 4 and 5, while the NIH SBIR/STTR Conference will be held in Albuquerque, New Mexico, from October 21-23.
Before you make changes to your grant, know whether you need to get NIAID's permission in advance.
Prior Approval Is Necessary
You must get our prior approval for some actions, like modifying the scope of your grant, transferring a grant from one institution to another, and changing from a single to multiple PI award, or vice versa. For the complete list, see our Prior Approvals for Post-Award Grant Actions SOP.
Keep in mind that there may be items specific to your grant for which you need prior approval, so check your Notice of Award.
Give yourself plenty of time to get approval by making your request at least 30 days before you want your proposed change to take effect. To be safe, you may want to check with your grants management specialist about how much time you'll need for the type of prior approval you're seeking.
Note: though your program officer can advise you, your grants management specialist is the one who will approve or disapprove your prior approval request.
Prior Approval Not Necessary
You don't need a green light from us to take the steps described in Grantees Can Take Many Actions Independently in the Strategy for NIH Funding.
If you have questions or are unsure whether you need prior approval, contact your grants management specialist.
You're waiting for your Notice of Award and want to start your project, but you need money to get it underway. What are you to do? Consider this: ask staff in your institutional business office for approval on preaward spending.
Getting permission before you spend is absolutely essential since your institution is responsible for your expenses in the event that we reduce your award or cannot issue your grant.
It's also important to keep in mind these key points:
If your institution gives you the green light to use its money, the only preaward spending costs you can incur are those that: 1) are needed to conduct the project and 2) would be allowable under the grant, if awarded, without NIH prior approval.
For competing grants, you can charge allowable preaward costs incurred up to 90 days before your initial Notice of Grant Award's budget period start date.
For noncompeting grants, you may incur preaward costs before the beginning date of a budget period without regard to the time parameters above. Check to see what expenses your business office will allow.
If you have any questions, contact your grants management specialist.
Feel free to send us a question at firstname.lastname@example.org. After responding to you, we may include your question in the newsletter, incorporate it into the NIAID Research Funding site, or both.
"Does NIAID sponsor individual researchers to attend conferences?"—anonymous reader
No. You may have noticed a recent funding opportunity announcement (FOA) called NIH Support for Conferences and Scientific Meetings. This FOA supports the scientific conferences themselves through the R13/U13 mechanism, which may include defraying registration costs for attendees, but not an individual's conference and travel expenses.
"What is the submission deadline for an AIDS-related F32 application?"—anonymous reader
May 7, 2014, for Cycle I. NIAID follows NIH's AIDS and AIDS-related dates for all activity codes, including the NRSA Individual Postdoctoral Fellowship (F32).
See other announcements at NIAID Funding Opportunities List.
back to top
Last Updated May 05, 2016
Last Reviewed April 17, 2014